University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Shigella CVD 31000: Study of Responses with Shigella-ETEC Vaccine Strain CVD 1208S-122

Phase 1

Active, not recruiting

Conditions: Shigella Infection
Enterotoxigenic Escherichia Coli Infection

Interventions: Biological: strain CVD 1208S-122
Other: Placebo

First Posted Date: 2020-11-18

Last Posted Date: 2024-11-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 54

Registration Number: NCT04634513

Locations: 🇺🇸
University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

Pilot Testing the Check Up

Not Applicable

Recruiting

Conditions: Cannabis Use Disorder

Interventions: Behavioral: Teen Marijuana Check Up

First Posted Date: 2020-11-10

Last Posted Date: 2023-09-28

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 40

Registration Number: NCT04624074

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer
Oropharyngeal Squamous Cell Carcinoma
Oropharynx Cancer

Interventions: Radiation: Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)

First Posted Date: 2020-10-30

Last Posted Date: 2024-07-16

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 52

Registration Number: NCT04609280

Locations: 🇺🇸
Maryland Proton Treatment Center, Baltimore, Maryland, United States
🇺🇸
UMMC, Baltimore, Maryland, United States
🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States

and more 3 locations

Treat COVID-19 Patients With Regadenoson

Phase 1

Completed

Conditions: COVID-19
Lung Inflammation

Interventions: Other: Placebo Control
Drug: Regadenoson

First Posted Date: 2020-10-28

Last Posted Date: 2023-08-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 5

Registration Number: NCT04606069

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Tendon Transfer Rotator Cuff Tear

Not Applicable

Recruiting

Conditions: Rotator Cuff Tears

Interventions: Procedure: Latissimus Dorsi Tendon Transfer Technique
Procedure: Pectoralis Tendon Transfer Technique
Procedure: Lower Trapezius Tendon Transfer Technique

First Posted Date: 2020-10-19

Last Posted Date: 2024-06-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 84

Registration Number: NCT04588506

Locations: 🇺🇸
U of Maryland Baltimore, Baltimore, Maryland, United States

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia

Not Applicable

Recruiting

Conditions: Trigeminal Neuralgia

Interventions: Device: ExAblate Transcranial treatment

First Posted Date: 2020-10-08

Last Posted Date: 2024-02-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 10

Registration Number: NCT04579692

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Hybrid Robot+FES Stroke Rehabilitation

Not Applicable

Recruiting

Conditions: Stroke

Interventions: Combination Product: Ankle robot training and functional electrical stimulation(FES) group
Combination Product: Ankle robot training group

First Posted Date: 2020-09-16

Last Posted Date: 2024-11-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 60

Registration Number: NCT04550728

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Trial of Therapeutic Hypothermia in Patients With ARDS

Phase 2

Recruiting

Conditions: Respiratory Distress Syndrome, Adult

Interventions: Device: Standard of care
Device: Hypothermia
Drug: Neuromuscular Blocking Agents

First Posted Date: 2020-09-11

Last Posted Date: 2024-10-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 340

Registration Number: NCT04545424

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 12 locations

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Phase 2

Recruiting

Conditions: Endometrial Cancer

Interventions: Drug: carboplatin and paclitaxel
Radiation: pelvic IMPT (Intensity Modulated Proton Therapy)

First Posted Date: 2020-08-27

Last Posted Date: 2024-05-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 21

Registration Number: NCT04527900

Locations: 🇺🇸
Maryland Proton Treatment Center, Baltimore, Maryland, United States
🇺🇸
Central Maryland Radiation Oncology, Columbia, Maryland, United States
🇺🇸
UMMC, Baltimore, Maryland, United States

and more 1 locations

Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

Early Phase 1

Completed

Conditions: Lung Transplant

Interventions: Drug: Placebo
Drug: Regadenoson

First Posted Date: 2020-08-20

Last Posted Date: 2024-08-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 47

Registration Number: NCT04521569

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy